Acetylcholinesterase — new roles for an old actor

Nature Reviews Neuroscience

Volumn 2, Issue 4, 2001, Pages 294-302

  Soreq, Hermona ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINESTERASE; CHOLINESTERASE INHIBITOR; DOPAMINE; MULTIENZYME COMPLEX;

ALTERNATIVE RNA SPLICING; ANIMAL; CELL ADHESION; CHEMISTRY; DEGENERATIVE DISEASE; EDITORIAL; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETICS; HEMATOPOIESIS; HUMAN; METABOLISM; MUTATION; NERVE CELL; PERSIAN GULF SYNDROME; PHENOTYPE; PROTEIN TRANSPORT; SENILE PLAQUE; STRESS; SYNAPSE;

ACETYLCHOLINESTERASE; ALTERNATIVE SPLICING; ANIMALS; CELL ADHESION; CHOLINESTERASE INHIBITORS; DOPAMINE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HEMATOPOIESIS; HUMANS; MULTIENZYME COMPLEXES; MUTATION; NEURODEGENERATIVE DISEASES; NEURONS; PERSIAN GULF SYNDROME; PHENOTYPE; PROTEIN TRANSPORT; SENILE PLAQUES; STRESS; SYNAPSES;

EID: 0035320772     PISSN: 1471003X     EISSN: 14710048     Source Type: Journal    
DOI: 10.1038/35067589     Document Type: Article

References (129)

1. Dale, H. The action of certain esters and ethers of choline, and their relation to muscarine. J. Pharmacol. Exp. Therap. 6, 147–190 (1914).
2. Loewi, O. & Navratil, E. Uber humorale Ubertragbarkeit der Herznervenwirkung. X Mitteilung. Pfluger’s Arch. 214, 678–688 (1926).
3. Wright, C. I., Geula, C. & Mesulam, M. M. Neurological cholinesterases in the normal brain and in Alzheimer’s disease: relationship to plaques, tangles, and patterns of selective vulnerability. Ann. Neurol. 34, 373–384 (1993).
4. Polinsky, R. J., Holmes, K. V., Brown, R. T. & Weise, V. CSF acetylcholinesterase levels are reduced in multiple system atrophy with autonomic failure. Neurology 39, 40–44 (1989).
5. Ohno, K. et al. The spectrum of mutations causing end-plate acetylcholinesterase deficiency. Ann. Neurol. 47, 162–170 (2000).
6. Silver, A. A histochemical investigation of cholinesterases at neuromuscular junctions in mammalian and avian muscle. J. Physiol. (Lond.) 169, 386–393 (1963).
7. Augustinsson, K. B. & Nachmansohn, D. Distinction between acetylcholinesterase and other choline estersplitting enzymes. Science 110, 98–99 (1949).
8. Li, B. et al. Abundant tissue butyrylcholinesterase and its possible function in the acetylcholinesterase knockout mouse. J. Neurochem. 75, 1320–1331 (2000).
9. Sussman, J. L. et al. Atomic structure of acetylcholinesterase from Torpedo californica: a prototypic acetylcholine-binding protein. Science 253, 872–879 (1991).
10. Bourne, Y., Taylor, P. & Marchot, P. Acetylcholinesterase inhibition by fasciculin: crystal structure of the complex. Cell 83, 503–512 (1995).
11. Harel, M. et al. Three-dimensional structures of Drosophila melanogaster acetylcholinesterase and of its complexes with two potent inhibitors. Protein Sci. 9, 1063–1072 (2000).
12. Kryger, G. et al. Structures of recombinant native and E202Q mutant human acetylcholinesterase complexed with the snake-venom toxin fasciculin-II. Acta Crystallogr. D Biol. Crystallogr. 56, 1385–1394 (2000).
13. Shafferman, A. et al. Mutagenesis of human acetylcholinesterase. Identification of residues involved in catalytic activity and in polypeptide folding. J. Biol. Chem. 267, 17640–17648 (1992).
14. Nair, H. K., Seravalli, J., Arbuckle, T. & Quinn, D. M. Molecular recognition in acetylcholinesterase catalysis: free-energy correlations for substrate turnover and inhibition by trifluoro ketone transition-state analogs. Biochemistry 33, 8566-8576 (1994).
15. Ripoll, D. R., Faerman, C. H., Axelsen, P. H., Silman, I. & Sussman, J. L. An electrostatic mechanism for substrate guidance down the aromatic gorge of acetylcholinesterase. Proc. Natl Acad. Sci. USA 90, 5128-5132 (1993).
16. Shafferman, A. et al. Electrostatic attraction by surface charge does not contribute to the catalytic efficiency of acetylcholinesterase. EMBO J. 13, 3448-3455 (1994).
17. Radic, Z., Kirchhoff, P. D., Quinn, D. M., McCammon, J. A. & Taylor, P. Electrostatic influence on the kinetics of ligand binding to acetylcholinesterase. Distinctions between active center ligands and fasciculin. J. Biol. Chem. 272, 23265-23277 (1997).
18. Taylor, P., Luo, Z. D. & Camp, S. in Cholinesterases and Cholinesterase Inhibitors (ed. Giacobini, E.) 63-79 (Martin Dunitz, London, 2000).
19. Botti, S. A., Felder, C. E., Sussman, J. L. & Silman, I. Electrotactins: a class of adhesion proteins with conserved electrostatic and structural motifs. Protein Eng. 11, 415-420 (1998).
20. Luo, Z. D., Camp, S., Mutero, A. & Taylor, P. Splicing of 5' introns dictates alternative splice selection of acetylcholinesterase pre-mRNA and specific expression during myogenesis. J. Biol. Chem. 273, 28486-28495 (1998).
21. Atanasova, E., Chiappa, S., Wieben, E. & Brimijoin, S. Novel messenger RNA and alternative promoter for murine acetylcholinesterase. J. Biol. Chem. 274, 21078-21084 (1999).
22. Li, Y., Camp, S., Rachinsky, T. L., Getman, D. & Taylor, P. Gene structure of mammalian acetylcholinesterase. Alternative exons dictate tissue-specific expression. J. Biol. Chem. 266, 23083-23090 (1991).
23. Bon, S., Coussen, F. & Massoulie, J. Quaternary associations of acetylcholinesterase. II. The polyproline attachment domain of the collagen tail. J. Biol. Chem. 3016-3021 (1997).
24. Donger, C. et al. Mutation in the human acetylcholinesterase-associated collagen gene, COLQ, is responsible for congenital myasthenic syndrome with end-plate acetylcholinesterase deficiency (Type Ic). Am. J. Hum. Genet. 63, 967-975 (1998).
25. Futerman, A. H., Low, M. G., Ackermann, K. E., Sherman, W. R. & Silman, I. Identification of covalently bound inositol in the hydrophobic membrane-anchoring domain of Torpedo acetylcholinesterase. Biochem. Biophys. Res. Commun. 129, 312-317 (1985).
26. Massoulie, J. et al. The polymorphism of acetylcholinesterase: post-translational processing, quaternary associations and localization. Chem. Biol. Interact 119-120, 29-42 (1999).
27. Fitzpatrick-McElligott, S. & Stent, G. S. Appearance and localization of acetylcholinesterase in embryos of the leech Helobdella triserialis. J. Neurosci. 1, 901-907 (1981).
28. Betz, H., Bourgeois, J. P. & Changeux, J. P. Evolution of cholinergic proteins in developing slow and fast skeletal muscles in chick embryo. J. Physiol. 302, 197-218 (1980).
29. Layer, P. G. Cholinesterases preceding major tracts in vertebrate neurogenesis. Bioessays 12, 415-420 (1990).
30. Kreutzberg, G. W. Neuronal dynamics and axonal flow. IV. Blockage of intra-axonal enzyme transport by colchicine. Proc. Natl Acad. Sci. USA 62, 722-728 (1969).
31. Appleyard, M. E. Secreted acetylcholinesterase: non- classical aspects of a classical enzyme. Trends Neurosci. 15, 485-490 (1992).
32. Small, D. H. Non-cholinergic actions of acetylcholinesterases: proteases regulating cell growth and development? Trends Biochem. Sci. 15, 213-216 (1990).
33. Checler, F., Grassi, J. & Vincent, J. P. Cholinesterases display genuine arylacylamidase activity but are totally devoid of intrinsic peptidase activities. J. Neurochem. 62, 756-763 (1994).
34. Layer, P. G., Weikert, T. & Alber, R. Cholinesterases regulate neurite growth of chick nerve cells in vitro by means of a non-enzymatic mechanism. Cell Tissue Res. 219-226 (1993).
35. Small, D. H., Reed, G., Whitefield, B. & Nurcombe, V. Cholinergic regulation of neurite outgrowth from isolated chick sympathetic neurons in culture. J. Neurosci. 15, 144-151 (1995).
36. Koenigsberger, C., Chiappa, S. & Brimijoin, S. Neurite differentiation is modulated in neuroblastoma cells engineered for altered acetylcholinesterase expression. J. Neurochem. 69, 1389-1397 (1997).
37. Grifman, M., Galyam, N., Seidman, S. & Soreq, H. Functional redundancy of acetylcholinesterase and neuroligin in mammalian neuritogenesis. Proc. Natl Acad. Sci. USA 95, 13935-13940 (1998).
38. Bigbee, J. W., Sharma, K. V., Chan, E. L. & Bogler, O. Evidence for the direct role of acetylcholinesterase in neurite outgrowth in primary dorsal root ganglion neurons. Brain Res. 861, 354-362 (2000).
39. de la Escalera, S., Bockamp, E. O., Moya, F., Piovant, M. & Jimenez, F. Characterization and gene cloning of neurotactin, a Drosophila transmembrane protein related to cholinesterases. EMBO J. 9, 3593-3601 (1990).
40. Darboux, I., Barthalay, Y., Piovant, M. & Hipeau Jacquotte, R. The structure-function relationships in Drosophila neurotactin show that cholinesterasic domains may have adhesive properties. EMBO J. 15, 4835-4843 (1996).
41. Sternfeld, M. et al. Acetylcholinesterase enhances neurite growth and synapse development through alternative contributions of its hydrolytic capacity, core protein, and variable C termini. J. Neurosci. 18, 1240-1249 (1998).
42. Scheiffele, P., Fan, J., Choih, J., Fetter, R. & Serafini, T. Neuroligin expressed in nonneuronal cells triggers presynaptic development in contacting axons. Cell 101, 657-669 (2000).
43. Song, J. Y., Ichtchenko, K., Sudhof, T. C. & Brose, N. Neuroligin 1 is a postsynaptic cell-adhesion molecule of excitatory synapses. Proc. Natl Acad. Sci. USA 96, 1100-1105 (1999).
44. Llinas, R. R. & Greenfield, S. A. On-line visualization of dendritic release of acetylcholinesterase from mammalian substantia nigra neurons. Proc. Natl Acad. Sci. USA 84, 3047-3050 (1987).
45. Holmes, C., Jones, S. A., Budd, T. C. & Greenfield, S. A. Non-cholinergic, trophic action of recombinant acetylcholinesterase on mid-brain dopaminergic neurons. J. Neurosci. Res. 49, 207-218 (1997).
46. Inestrosa, N. C. et al. Acetylcholinesterase accelerates assembly of amyloid-p peptides into Alzheimer's fibrils: possible role of the peripheral site of the enzyme. Neuron 16, 881-891 (1996).
47. Paoletti, F., Mocali, A. & Vannucchi, A. M. Acetylcholinesterase in murine erythroleukemia (Friend) cells: evidence for megakaryocyte-like expression and potential growth-regulatory role of enzyme activity. Blood 79, 2873-2879 (1992).
48. Lev-Lehman, E., Deutsch, V., Eldor, A. & Soreq, H. Immature human megakaryocytes produce nuclear- associated acetylcholinesterase. Blood 89, 3644-3653 (1997).
49. Kawashima, K. & Fujii, T. Extraneuronal cholinergic system in lymphocytes. Pharmacol. Ther. 86, 29-48 (2000).
50. Soreq, H. et al. Antisense oligonucleotide inhibition of acetylcholinesterase gene expression induces progenitor cell expansion and suppresses hematopoietic apoptosis ex vivo. Proc. Natl Acad. Sci. USA 91, 7907-7911 (1994).
51. Brown, L. M. et al. Pesticide exposure and other agricultural risk factors for leukemia among men in Iowa and Minnesota. Cancer Res. 50, 6585-6591 (1990).
52. Lev-Lehman, E. et al. Synaptogenesis and myopathy under acetylcholinestrase overexpression. J. Mol. Neurosci. 14, 93-105 (2000).
53. Lapidot-Lifson, Y. et al. Coamplification of human acetylcholinesterase and butyrylcholinesterase genes in blood cells: correlation with various leukemias and abnormal megakaryocytopoiesis. Proc. Natl Acad. Sci. USA 86, 4715-4719 (1989).
54. Stephenson, J., Czepulkowski, B., Hirst, W. & Mufti, G. Deletion of the acetylcholinesterase locus at 7q22 associated with myelodysplastic syndromes (MDS) and acute myeloid leukaemia (AML). Leuk Res. 20, 235-241 (1996).
55. Velan, B. et al. N-glycosylation of human acetylcholinesterase: effects on activity, stability and biosynthesis. Biochem. J. 296, 649-656 (1993).
56. Chan, R. Y., Adatia, F. A., Krupa, A. M. & Jasmin, B. J. Increased expression of acetylcholinesterase T and R transcripts during hematopoietic differentiation is accompanied by parallel elevations in the levels of their respective molecular forms. J. Biol. Chem. 273, 9727-9733 (1998).
57. Camp, S. & Taylor, P. in Structure and Function of Cholinesterases and Related Proteins (eds Doctor, B. P., Taylor, P., Quinn, D. M., Rotundo, R. L. & Gentry, M. K.) 51–55 (Plenum, New York, 1998).
58. Grisaru, D. et al. ARP, a peptide derived from the stress- associated acetylcholinesterase variant has hematopoietic growth promoting activities. Mol. Med. (in the press).
59. Li, Y., Camp, S., Rachinsky, T. L., Bongiorno, C. & Taylor, P. Promoter elements and transcriptional control of the mouse acetylcholinesterase gene. J. Biol. Chem. 268, 3563-3572 (1993).
60. Shapira, M. et al. A transcription-activating polymorphism in the ACHE promoter associated with acute sensitivity to anti-acetylcholinesterases. Hum. Mol. Genet. 9, 1273-1281 (2000).
61. Chan, R. Y., Boudreau-Lariviere, C., Angus, L. M., Mankal, F. A. & Jasmin, B. J. An intronic enhancer containing an N-box motif is required for synapse- and tissue-specific expression of the acetylcholinesterase gene in skeletal muscle fibers. Proc. Natl Acad. Sci. USA 96, 4627-4632 (1999).
62. Rotundo, R. L. Nucleus-specific translation and assembly of acetylcholinesterase in multinucleated muscle cells. J. Cell Biol. 110, 715-719 (1990).
63. Galyam, N. et al. Complex host cell responses to antisense suppression of ACHE gene expression. Antisense Nucl. Acid Drug Dev. 11, 51-57 (2001).
64. Kaufer, D., Friedman, A., Seidman, S. & Soreq, H. Acute stress facilitates long-lasting changes in cholinergic gene expression. Nature 393, 373-377 (1998).
65. Nordberg, A., Hellstrom-Lindahl, E., Almkvist, O. & Meurling, L. Activity of acetylcholinesterase in CSF increases in Alzheimer's patients after treatment with tacrine. Alzheimer's Reports 2, 347-352 (1999).
66. Grisaru, D. et al. Human osteogenesis involves differentiation-dependent increases in the morphogenically active 3' alternative splicing variant of acetylcholinesterase. Mol. Cell. Biol. 19, 788-795 (1999).
67. Schober, A. et al. Reduced acetylcholinesterase (AChE) activity in adrenal medulla and loss of sympathetic preganglionic neurons in TrkA-deficient, but not TrkB- deficient, mice. J. Neurosci. 17, 891-903 (1997).
68. Robertson, R. T. et al. Do subplate neurons comprise a transient population of cells in developing neocortex of rats? J. Comp. Neurol. 426, 632-650 (2000).
69. Shohami, E. et al. Antisense prevention of neuronal damages following head injury in mice. J. Mol. Med. 78, 228-236 (2000).
70. Gray, R., Rajan, A. S., Radcliffe, K. A., Yakehiro, M. & Dani, J. A. Hippocampal synaptic transmission enhanced by low concentrations of nicotine. Nature 383, 713-716 (1996).
71. Ashani, Y. et al. Butyrylcholinesterase and acetylcholinesterase prophylaxis against soman poisoning in mice. Biochem. Pharmacol. 41, 37-41 (1991).
72. Evans, W. E. & Relling, M. V. Pharmacogenomics: translating functional genomics into rational therapeutics. Science 286, 487-491 (1999).
73. Luo, Z. D. et al. Calcineurin enhances acetylcholinesterase mRNA stability during C2-C12 muscle cell differentiation. Mol. Pharmacol. 56, 886-894 (1999).
74. Giacobini, E. in Cholinesterases and Cholinesterase Inhibitors (ed. Giacobini, E.) 181-226 (Martin Dunitz, London, 2000).
75. Erb, C. et al. Compensatory mechanisms facilitate hippocampal acetylcholine release in transgenic mice expressing human acetylcholinesterase. J. Neurochem. (in the press).
76. Pollet, C. et al. Medical evaluation of Persian Gulf veterans with fatigue and/or chemical sensitivity. J. Med. 29, 101-113 (1998).
77. Okumura, T. et al. Report on 640 victims of the Tokyo subway sarin attack. Ann. Emerg. Med. 28, 129-135 (1996).
78. Ohno, K., Brengman, J., Tsujino, A. & Engel, A. G. Human endplate acetylcholinesterase deficiency caused by mutations in the collagen-like tail subunit (ColQ) of the asymmetric enzyme. Proc. Natl Acad. Sci. USA 95, 9654-9659 (1998).
79. Fournier, D. et al. Drosophila melanogaster acetylcholinesterase gene. Structure, evolution and mutations. J. Mol. Biol. 210, 15-22 (1989).
80. Prody, C. A., Dreyfus, P., Zamir, R., Zakut, H. & Soreq, H. De novo amplification within a 'silent' human cholinesterase gene in a family subjected to prolonged exposure to organophosphorous insecticides. Proc. Natl Acad. Sci. USA 86, 690-694 (1989).
81. Bartels, C. F., Zelinski, T. & Lockridge, O. Mutation at codon 322 in the human acetylcholinesterase (ACHE) gene accounts for YT blood group polymorphism. Am. J. Hum. Genet. 52, 928-936 (1993).
82. Ehrlich, G. et al. Population diversity and distinct haplotype frequencies associated with ACHE and BCHE genes of Israeli Jews from trans-Caucasian Georgia and from Europe. Genomics 22, 288-295 (1994).
83. La Du, B. N. et al. Phenotypic and molecular biological analysis of human butyrylcholinesterase variants. Clin. Biochem. 23, 423-431 (1990).
84. Beeri, R. et al. Transgenic expression of human acetylcholinesterase induces progressive cognitive deterioration in mice. Curr. Biol. 5, 1063-1071 (1995).
85. Xie, W. et al. Postnatal developmental delay and supersensitivity to organophosphate in gene-targeted mice lacking acetylcholinesterase. J. Pharmacol. Exp. Ther. 293, 896-902 (2000).
86. von der Kammer, H. et al. Muscarinic acetylcholine receptors activate expression of the EGR gene family of transcription factors. J. Biol. Chem. 273, 14538-14544 (1998).
87. Xie, J. & McCobb, D. P. Control of alternative splicing of potassium channels by stress hormones. Science 280, 443-446 (1998).
88. Daoud, R., Da Penha Berzaghi, M., Siedler, F., Hubener, M. & Stamm, S. Activity-dependent regulation of alternative splicing patterns in the rat brain. Eur. J. Neurosci. 11, 788-802 (1999).
89. Combes, D., Fedon, Y., Grauso, M., Toutant, J. P. & Arpagaus, M. Four genes encode acetylcholinesterases in the nematodes Caenorhabditis elegans and Caenorhabditis briggsae. cDNA sequences, genomic structures, mutations and in vivo expression. J. Mol. Biol. 300, 727-742 (2000).
90. Anglister, L., Stiles, J. R. & Salpeter, M. M. Acetylcholinesterase density and turnover number at frog neuromuscular junctions, with modeling of their role in synaptic function. Neuron 12, 783-794 (1994).
91. Peng, H. B., Xie, H., Rossi, S. G. & Rotundo, R. L. Acetylcholinesterase clustering at the neuromuscular junction involves perlecan and dystroglycan. J. Cell Biol. 145, 911-921 (1999).
92. Seidman, S. et al. Synaptic and epidermal accumulations of human acetylcholinesterase are encoded by alternative 3'-terminal exons. Mol. Cell. Biol. 15, 2993-3002 (1995).
93. Harlow, M. L., Ress, D., Stoschek, A., Marshall, R. M. & McMahan, U. J. The architecture of active zone material at the frog's neuromuscular junction. Nature 409, 479-484 (2001).
94. Feng, G. et al. Genetic analysis of collagen Q: roles in acetylcholinesterase and butyrylcholinesterase assembly and in synaptic structure and function. J. Cell Biol. 144, 1349-1360 (1999).
95. Karpel, R. et al. Overexpression of alternative human acetylcholinesterase forms modulates process extensions in cultured glioma cells. J. Neurochem. 66, 114-123 (1996).
96. Sternfeld, M. et al. Excess 'readthrough' acetylcholinesterase attenuates but the 'synaptic' variant intensifies neurodeterioration correlates. Proc. Natl Acad. Sci. USA 97, 8647-8652 (2000).
97. Chien, C. T., Bartel, P. L., Sternglanz, R. & Fields, S. The two-hybrid system: a method to identify and clone genes for proteins that interact with a protein of interest. Proc. Natl Acad. Sci. USA 88, 9578-9582 (1991).
98. Nissim, A. et al. Antibody fragments from a 'single pot' phage display library as immunochemical reagents. EMBO J. 13, 692-698 (1994).
99. Mayford, M., Abel, T. & Kandel, E. R. Transgenic approaches to cognition. Curr. Opin. Neurobiol. 5, 141-148 (1995).
100. Young, R. A. Biomedical discovery with DNA arrays. Cell 102, 9-15 (2000).
101. Mezey, E., Chandross, K. J., Harta, G., Maki, R. A. & McKercher, S. R. Turning blood into brain: cells bearing neuronal antigens generated in vivo from bone marrow. Science 290, 1779-1782 (2000).
102. Kuhl, D. E. et al. In vivo mapping of cerebral acetylcholinesterase activity in aging and Alzheimer's disease. Neurology 52, 691-699 (1999).
103. Shinotoh, H. et al. Positron emission tomographic measurement of acetylcholinesterase activity reveals differential loss of ascending cholinergic systems in Parkinson's disease and progressive supranuclear palsy. Ann. Neurol. 46, 62-69 (1999).
104. Vereker, E., O'Donnell, E. & Lynch, M. A. The inhibitory effect of interleukin-1 p on long-term potentiation is coupled with increased activity of stress-activated protein kinases. J. Neurosci. 20, 6811-6819 (2000).
105. Xu, L., Anwyl, R. & Rowan, M. J. Behavioural stress facilitates the induction of long-term depression in the hippocampus. Nature 387, 497-500 (1997).
106. Hamilton, S. E. et al. Disruption of the m1 receptor gene ablates muscarinic receptor-dependent M current regulation and seizure activity in mice. Proc. Natl Acad. Sci. USA 94, 13311-13316 (1997).
107. Gennari, K., Brunner, J. & Brodbeck, U. Tetrameric detergent-soluble acetylcholinesterase from human caudate nucleus: subunit composition and number of active sites. J. Neurochem. 49, 12-18 (1987).
108. Franklin, R. B. J. & Paxinos, G. The Mouse Brain in Stereotaxic Coordinates (Academic, San Diego, 1997).
109. Holmstedt, B. in Cholinesterases and Cholinesterase Inhibitors: Basic, Preclinical and Clinical Aspects (ed. Giacobini, E.) 1-8 (Martin Dunitz, London, 2000).
110. Abramson, S. N., Radic, Z., Manker, D., Faulkner, D. J. & Taylor, P. Onchidal: a naturally occurring irreversible inhibitor of acetylcholinesterase with a novel mechanism of action. Mol. Pharmacol. 36, 349-354 (1989).
111. Carmichael, W. The toxins of cyanobacteria. Sci. Am. 270, 78-86 (1994).
112. Wilson, I. B. Molecular complementarity and antidotes for alkylphosphate poisoning. Fed. Proc. 18, 752-758 (1959).
113. Keeler, J. R., Hurst, C. G. & Dunn, M. A. Pyridostigmine used as a nerve agent pretreatment under wartime conditions. J. Am. Med. Assoc. 266, 693-695 (1991).
114. Haley, R. W., Kurt, T. L. & Hom, J. Is there a Gulf War Syndrome? Searching for syndromes by factor analysis of symptoms. J. Am. Med. Assoc. 277, 215-222 (1997).
115. Sapolsky, R. M. The stress of Gulf War syndrome. Nature Med. 393, 308-309 (1998).
116. Friedman, A. et al. Pyridostigmine brain penetration under stress enhances neuronal excitability and induces early immediate transcriptional response. Nature Med. 2, 1382-1385 (1996).
117. Grauer, E., Alkalai, D., Kapon, J., Cohen, G. & Raveh, L. Stress does not enable pyridostigmine to inhibit brain cholinesterase after parenteral administration. Toxicol. Appl. Pharmacol. 164, 301-304 (2000).
118. Lallement, G. et al. Heat stress, even extreme, does not induce penetration of pyridostigmine into the brain of guinea pigs. Neurotoxicology 19, 759-766 (1998).
119. Esposito, P. et al. Acute stress increases permeability of the blood-brain-barrier through activation of brain mast cells. Brain Res. 888, 117-127 (2001).
120. Grauer, E. et al. Viral neuroinvasion as a marker for BBB integrity following exposure to cholinesterase inhibitors. Life Sci. 68, 985-990 (2001).
121. Relyea, R. A. & Mills, N. Predator-induced stress makes the pesticide carbaryl more deadly to gray treefrog tadpoles (Hyla versicolor). Proc. Natl Acad. Sci. USA 98, 2491-2496 (2001).
122. Coyle, J. T., Price, D. L. & DeLong, M. R. Alzheimer's disease: a disorder of cortical cholinergic innervation. Science 219, 1184-1190 (1983).
123. Patrick, J. & Lindstrom, J. Autoimmune response to acetylcholine receptor. Science 180, 871-872 (1973).
124. Keesey, J. C. Contemporary opinions about Mary Walker: a shy pioneer of therapeutic neurology. Neurology 51, 1433-1439 (1998).
125. Beeri, R. et al. Enhanced hemicholinium binding and attenuated dendrite branching in cognitively impaired acetylcholinesterase-transgenic mice. J. Neurochem. 69, 2441-2451 (1997).
126. Alvarez, A. et al. Stable complexes involving acetylcholinesterase and amyloid-p peptide change the biochemical properties of the enzyme and increase the neurotoxicity of Alzheimer's fibrils. J. Neurosci. 18, 3213-3223 (1998).
127. Sberna, G. et al. Acetylcholinesterase is increased in the brains of transgenic mice expressing the C-terminal fragment (CT100) of the p-amyloid protein precursor of Alzheimer's disease. J. Neurochem. 71, 723-731 (1998).
128. Wilson, B. W. & Viola, G. A. Multiple forms of acetylcholinesterase in nutritional and inherited muscular dystrophy of the chicken. J. Neurol. Sci. 16, 183-192 (1972).
129. Silman, I., di Giamberardino, L., Lyles, L., Couraud, J. Y. & Barnard, E. A. Parallel regulation of acetylcholinesterase and pseudocholinesterase in normal, denervated and dystrophic chicken skeletal muscle. Nature 280, 160-162 (1979)